RxDoctor Payments Data

Jeffrey Infante

Medical Oncology · Nashville, TNNPI 1396848271

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Genentech, Inc.. That places this record below the midpoint for medical oncology clinicians in TN, where the typical reported total is $6,231.

$144in general payments, 2019–2025

Across 1 payment — averaging $143.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$144
$670,807in research payments, 2019–2025

Across 68 payments — averaging $9864.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$308K
  • GSK$215K
  • Astrazeneca UK Limited$40K
  • PTC Therapeutics, Inc.$37K
  • AstraZeneca$29K
  • Janssen Research & Development, LLC$19K
  • plus $23K from 4 others

What the payments were for

  • Food & beverage$144100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.1$144

How this compares

$144 in reported general payments places this provider in the 15th percentile of 101 medical oncology providers in Tennessee.

See all medical oncology providers in Tennessee

Other medical oncology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →